Your browser doesn't support javascript.
International Prevalence and Mechanisms of SARS-CoV-2 in Childhood Arterial Ischemic Stroke During the COVID-19 Pandemic.
Beslow, Lauren A; Agner, Shannon C; Santoro, Jonathan D; Ram, Dipak; Wilson, Jenny L; Harrar, Dana; Appavu, Brian; Fraser, Stuart M; Rossor, Thomas; Torres, Marcela D; Kossorotoff, Manoëlle; Zuñiga Zambrano, Yenny C; Hernández-Chávez, Marta; Hassanein, Sahar M A; Zafeiriou, Dimitrios; Dowling, Michael M; Kopyta, Ilona; Stence, Nicholas V; Bernard, Timothy J; Dlamini, Nomazulu.
  • Beslow LA; Division of Neurology, Children's Hospital of Philadelphia, Departments of Neurology and Pediatrics, Perelman School of Medicine at the University of Pennsylvania (L.A.B.).
  • Agner SC; Division of Pediatric and Developmental Neurology, St. Louis Children's Hospital, Washington University School of Medicine, MO (S.C.A.).
  • Santoro JD; Division of Neurology, Children's Hospital Los Angeles, Department of Neurology, Keck School of Medicine at USC, CA (J.D.S.).
  • Ram D; Department of Paediatric Neurology, Royal Manchester Children's Hospital, England, United Kingdom (D.R.).
  • Wilson JL; Department of Pediatrics, Division of Pediatric Neurology, Oregon Health & Science University, Portland (J.L.W.).
  • Harrar D; Division of Neurology, Children's National Medical Center, Washington' D.C. (D.H.).
  • Appavu B; Divison of Neurology, Phoenix Children's Hospital, University of Arizona College of Medicine - Phoenix (B.A.).
  • Fraser SM; Division of Neurology, Children's Memorial Hermann Hospital, Houston' TX (S.M.F.).
  • Rossor T; Evelina London Children's Hospital, England, United Kingdom (T.R.).
  • Torres MD; Division of Hematology, Cook Children's Medical Center, Fort Worth, TX (M.D.T.).
  • Kossorotoff M; French Center for Pediatric Stroke, Pediatric Neurology Department, APHP University Hospital Necker-Enfants maladies, Paris, France (M.K.).
  • Zuñiga Zambrano YC; Unit of Pediatric Neurology, HOMI Fundación Hospital Pediátrico la Misericordia, Bogotá, Colombia (Y.C.Z.Z.).
  • Hernández-Chávez M; Unit of Pediatric Neurology, Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago (M.H.-C.).
  • Hassanein SMA; Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt (S.M.A.H.).
  • Zafeiriou D; Department of Pediatrics, Hippokratio General Hospital, Aristotle University, Thessaloniki, Greece (D.Z.).
  • Dowling MM; Departments of Pediatrics and Neurology, University of Texas Southwestern Medical Center, Dallas (M.M.D.).
  • Kopyta I; Department of Child Neurology, Medical University of Silesia in Katowice, Poland (I.K.).
  • Stence NV; Section of Pediatric Radiology, Children's Hospital Colorado, Department of Radiology, University of Colorado School of Medicine' Aurora (N.V.S.).
  • Bernard TJ; Section of Child Neurology, Children's Hospital Colorado, Departments of Pediatrics and Neurology, Hemophilia and Thrombosis Center, University of Colorado School of Medicine, Aurora (T.J.B.).
  • Dlamini N; Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Child Health Evaluative Sciences Program, University of Toronto, ON, Canada (N.D.).
Stroke ; 53(8): 2497-2503, 2022 08.
Article in English | MEDLINE | ID: covidwho-1962530
ABSTRACT

BACKGROUND:

Data from the early pandemic revealed that 0.62% of children hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had an acute arterial ischemic stroke (AIS). In a larger cohort from June 2020 to December 2020, we sought to determine whether our initial point estimate was stable as the pandemic continued and to understand radiographic and laboratory data that may clarify mechanisms of pediatric AIS in the setting of SARS-CoV-2.

METHODS:

We surveyed international sites with pediatric stroke expertise to determine numbers of hospitalized SARS-CoV-2 patients <18 years, numbers of incident AIS cases among children (29 days to <18 years), frequency of SARS-CoV-2 testing for children with AIS, and numbers of childhood AIS cases positive for SARS-CoV-2 June 1 to December 31, 2020. Two stroke neurologists with 1 neuroradiologist determined whether SARS-CoV-2 was the main stroke risk factor, contributory, or incidental.

RESULTS:

Sixty-one centers from 21 countries provided AIS data. Forty-eight centers (78.7%) provided SARS-CoV-2 hospitalization data. SARS-CoV-2 testing was performed in 335/373 acute AIS cases (89.8%) compared with 99/166 (59.6%) in March to May 2020, P<0.0001. Twenty-three of 335 AIS cases tested (6.9%) were positive for SARS-CoV-2 compared with 6/99 tested (6.1%) in March to May 2020, P=0.78. Of the 22 of 23 AIS cases with SARS-CoV-2 in whom we could collect additional data, SARS-CoV-2 was the main stroke risk factor in 6 (3 with arteritis/vasculitis, 3 with focal cerebral arteriopathy), a contributory factor in 13, and incidental in 3. Elevated inflammatory markers were common, occurring in 17 (77.3%). From centers with SARS-CoV-2 hospitalization data, of 7231 pediatric patients hospitalized with SARS-CoV-2, 23 had AIS (0.32%) compared with 6/971 (0.62%) from March to May 2020, P=0.14.

CONCLUSIONS:

The risk of AIS among children hospitalized with SARS-CoV-2 appeared stable compared with our earlier estimate. Among children in whom SARS-CoV-2 was considered the main stroke risk factor, inflammatory arteriopathies were the stroke mechanism.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Stroke / Ischemic Stroke / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Child / Humans Language: English Journal: Stroke Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Stroke / Ischemic Stroke / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Child / Humans Language: English Journal: Stroke Year: 2022 Document Type: Article